Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose erythropoietin to prevent ischemia-reperfusion injury in human forearm model
2007-001089-33Phase 3Completed
- Sponsor
- University Medical Center Groningen
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in myocardial ischemia-reperfusion injury, None, sponsored by University Medical Center Groningen. Started May 2008; status: completed.
02
Drugs
epoetin alfa
03
Conditions
myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on 2007-001089-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001089-33.